BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11380603)

  • 1. Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy.
    Sezer O; Niemöller K; Kaufmann O; Eucker J; Jakob C; Zavrski I; Possinger K
    Eur J Haematol; 2001 Apr; 66(4):238-44. PubMed ID: 11380603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.
    Sezer O; Niemöller K; Eucker J; Jakob C; Kaufmann O; Zavrski I; Dietel M; Possinger K
    Ann Hematol; 2000 Oct; 79(10):574-7. PubMed ID: 11100749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.
    Rajkumar SV; Fonseca R; Witzig TE; Gertz MA; Greipp PR
    Leukemia; 1999 Mar; 13(3):469-72. PubMed ID: 10086738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow angiogenesis in multiple myeloma: effect of therapy.
    Kumar S; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Greipp PR; Rajkumar SV
    Br J Haematol; 2002 Dec; 119(3):665-71. PubMed ID: 12437642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.
    Munshi NC; Wilson C
    Semin Oncol; 2001 Dec; 28(6):565-9. PubMed ID: 11740810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial.
    Oh HS; Choi JH; Park CK; Jung CW; Lee SI; Park Q; Suh C; Kim SB; Chi HS; Lee JH; Cho EK; Bang SM; Ahn MJ
    Int J Hematol; 2002 Dec; 76(5):465-70. PubMed ID: 12512842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
    Kumar S; Witzig TE; Dispenzieri A; Lacy MQ; Wellik LE; Fonseca R; Lust JA; Gertz MA; Kyle RA; Greipp PR; Rajkumar SV
    Leukemia; 2004 Mar; 18(3):624-7. PubMed ID: 14749707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
    Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Wellik LA; Fonseca R; Lust JA; Witzig TE; Kyle RA; Greipp PR; Rajkumar SV
    Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
    Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
    Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
    Rana C; Sharma S; Agrawal V; Singh U
    Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy.
    Dunphy F; Stack BC; Boyd JH; Dunleavy TL; Kim HJ; Dunphy CH
    Anticancer Res; 2002; 22(3):1755-8. PubMed ID: 12168864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow microvessel density and its prognostic significance in AML.
    Rabitsch W; Sperr WR; Lechner K; Chott A; Prinz E; Valent P; Kalhs P
    Leuk Lymphoma; 2004 Jul; 45(7):1369-73. PubMed ID: 15359635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity.
    Alexandrakis MG; Passam FH; Pappa CA; Dambaki C; Sfakiotaki G; Alegakis AK; Kyriakou DS; Stathopoulos E
    Int J Immunopathol Pharmacol; 2004; 17(1):49-56. PubMed ID: 15000866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.